CR20140473A - Compuestos de pirazol como inhibidores de sglt1 - Google Patents
Compuestos de pirazol como inhibidores de sglt1Info
- Publication number
- CR20140473A CR20140473A CR20140473A CR20140473A CR20140473A CR 20140473 A CR20140473 A CR 20140473A CR 20140473 A CR20140473 A CR 20140473A CR 20140473 A CR20140473 A CR 20140473A CR 20140473 A CR20140473 A CR 20140473A
- Authority
- CR
- Costa Rica
- Prior art keywords
- sglt1 inhibitors
- pirazol
- compounds
- pirazol compounds
- diabetes
- Prior art date
Links
- 108091006277 SLC5A1 Proteins 0.000 title 1
- 102000058090 Sodium-Glucose Transporter 1 Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 208000035474 group of disease Diseases 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/06—Heterocyclic radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261645101P | 2012-05-10 | 2012-05-10 | |
| US201361769221P | 2013-02-26 | 2013-02-26 | |
| PCT/US2013/039164 WO2013169546A1 (en) | 2012-05-10 | 2013-05-02 | Pyrazole compounds as sglt1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20140473A true CR20140473A (es) | 2014-11-21 |
Family
ID=48428684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20140473A CR20140473A (es) | 2012-05-10 | 2014-10-10 | Compuestos de pirazol como inhibidores de sglt1 |
Country Status (42)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA113086C2 (xx) * | 2012-05-10 | 2016-12-12 | Піразольні сполуки як інгібітори sglt1 | |
| TW201425326A (zh) | 2012-10-05 | 2014-07-01 | Lilly Co Eli | 新穎脲化合物 |
| TWI633113B (zh) | 2013-10-17 | 2018-08-21 | 美國禮來大藥廠 | 新穎脲化合物 |
| JO3298B1 (ar) | 2013-11-01 | 2018-09-16 | Lilly Co Eli | مشتقات جليكوبيرانوسيل-مستبدل و اندول-يوريا و استعمالاتهم كمثبطات sglt |
| AR098670A1 (es) * | 2013-11-08 | 2016-06-08 | Lilly Co Eli | Inhibidor de sglt1 |
| CN110054657B (zh) * | 2018-01-18 | 2021-06-29 | 亚宝药业集团股份有限公司 | 吡喃葡萄糖取代的吡唑化合物及其制备方法 |
| KR102806676B1 (ko) * | 2018-04-04 | 2025-05-13 | 니뽄 다바코 산교 가부시키가이샤 | 헤테로아릴로 치환된 피라졸 화합물 및 그의 의약 용도 |
| AU2020341926A1 (en) * | 2019-09-04 | 2022-03-17 | Japan Tobacco Inc. | Therapeutic or prophylactic method for diabetes using combination medicine |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100591585B1 (ko) | 1999-08-31 | 2006-06-20 | 깃세이 야쿠힌 고교 가부시키가이샤 | 글루코피라노실옥시피라졸 유도체, 그것을 함유하는 의약조성물 및 그 제조 중간체 |
| JP4141258B2 (ja) | 2001-02-26 | 2008-08-27 | キッセイ薬品工業株式会社 | グルコピラノシルオキシピラゾール誘導体及びその医薬用途 |
| US7217697B2 (en) | 2001-05-30 | 2007-05-15 | Kissei Pharmaceutical Co., Ltd. | Glucopyranosyloxypyrazole derivative medicinal composition containing the same medicinal use thereof and intermediate therefor |
| WO2004014932A1 (ja) * | 2002-08-08 | 2004-02-19 | Kissei Pharmaceutical Co., Ltd. | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
| JP2004137245A (ja) | 2002-08-23 | 2004-05-13 | Kissei Pharmaceut Co Ltd | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
| DE102004028241B4 (de) | 2004-06-11 | 2007-09-13 | Sanofi-Aventis Deutschland Gmbh | Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel |
| US7973012B2 (en) * | 2006-05-19 | 2011-07-05 | Taisho Pharmaceutical Co., Ltd | C-phenyl glycitol compound |
| JP5144683B2 (ja) | 2007-12-27 | 2013-02-13 | キッセイ薬品工業株式会社 | ピラゾール誘導体のモノセバシン酸塩 |
| MY155658A (en) | 2009-02-23 | 2015-11-13 | Taisho Pharmaceutical Co Ltd | A-isopropylphenyl glucitol compounds as sglti inhibitors |
| US20120270819A1 (en) * | 2009-10-02 | 2012-10-25 | Sanofi | Use of compounds with sglt-1/sglt-2 inhibitor activity for producing medicaments for treatment of bone disease |
| US8163704B2 (en) | 2009-10-20 | 2012-04-24 | Novartis Ag | Glycoside derivatives and uses thereof |
| UA113086C2 (xx) * | 2012-05-10 | 2016-12-12 | Піразольні сполуки як інгібітори sglt1 |
-
2013
- 2013-02-05 UA UAA201412088A patent/UA113086C2/uk unknown
- 2013-04-23 AR ARP130101348A patent/AR090806A1/es active IP Right Grant
- 2013-04-23 JO JOP/2013/0117A patent/JO3136B1/ar active
- 2013-04-25 TW TW102114877A patent/TWI579295B/zh active
- 2013-05-02 EP EP13722231.1A patent/EP2850084B1/en active Active
- 2013-05-02 US US13/875,314 patent/US8697849B2/en active Active
- 2013-05-02 AP AP2014008044A patent/AP3593A/xx active
- 2013-05-02 SG SG11201407345QA patent/SG11201407345QA/en unknown
- 2013-05-02 HU HUE13722231A patent/HUE030414T2/en unknown
- 2013-05-02 HR HRP20160804TT patent/HRP20160804T1/hr unknown
- 2013-05-02 SI SI201330209A patent/SI2850084T1/sl unknown
- 2013-05-02 PL PL13722231T patent/PL2850084T3/pl unknown
- 2013-05-02 DK DK13722231.1T patent/DK2850084T3/en active
- 2013-05-02 RS RS20160626A patent/RS55107B1/sr unknown
- 2013-05-02 ME MEP-2016-121A patent/ME02405B/me unknown
- 2013-05-02 IN IN7996DEN2014 patent/IN2014DN07996A/en unknown
- 2013-05-02 NZ NZ700356A patent/NZ700356A/en unknown
- 2013-05-02 PT PT137222311T patent/PT2850084T/pt unknown
- 2013-05-02 CA CA2869323A patent/CA2869323C/en active Active
- 2013-05-02 MX MX2014013615A patent/MX357058B/es active IP Right Grant
- 2013-05-02 EA EA201491852A patent/EA024207B1/ru not_active IP Right Cessation
- 2013-05-02 WO PCT/US2013/039164 patent/WO2013169546A1/en not_active Ceased
- 2013-05-02 JP JP2015511518A patent/JP6148725B2/ja active Active
- 2013-05-02 PE PE2014001716A patent/PE20142399A1/es active IP Right Grant
- 2013-05-02 LT LTEP13722231.1T patent/LT2850084T/lt unknown
- 2013-05-02 BR BR112014026198-9A patent/BR112014026198B1/pt active IP Right Grant
- 2013-05-02 KR KR1020147031119A patent/KR101685779B1/ko active Active
- 2013-05-02 AU AU2013259946A patent/AU2013259946B2/en active Active
- 2013-05-02 MY MYPI2014703279A patent/MY177326A/en unknown
- 2013-05-02 ES ES13722231.1T patent/ES2588835T3/es active Active
-
2014
- 2014-02-18 US US14/182,354 patent/US9296775B2/en active Active
- 2014-09-30 TN TNP2014000410A patent/TN2014000410A1/fr unknown
- 2014-10-10 CR CR20140473A patent/CR20140473A/es unknown
- 2014-10-16 ZA ZA2014/07531A patent/ZA201407531B/en unknown
- 2014-10-22 CL CL2014002845A patent/CL2014002845A1/es unknown
- 2014-10-30 IL IL235427A patent/IL235427A/en active IP Right Grant
- 2014-11-03 DO DO2014000250A patent/DOP2014000250A/es unknown
- 2014-11-05 GT GT201400242A patent/GT201400242A/es unknown
- 2014-11-05 MA MA37501A patent/MA37501B1/fr unknown
- 2014-11-07 EC ECIEPI201426088A patent/ECSP14026088A/es unknown
- 2014-11-07 PH PH12014502492A patent/PH12014502492B1/en unknown
- 2014-11-11 CO CO14249415A patent/CO7141429A2/es unknown
-
2016
- 2016-08-11 CY CY20161100801T patent/CY1117912T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20140473A (es) | Compuestos de pirazol como inhibidores de sglt1 | |
| GT201500081A (es) | Derivados de exendina-4 como agonistas duales de glp1/glucagón | |
| GT201300215A (es) | Inhibidores de glucosilceramida sintasa | |
| GT201400279A (es) | Jeringa | |
| GT201500051A (es) | Inhibidores de glucosilceramida sintasa | |
| BR112014032990A2 (pt) | seringa | |
| CO2017002719A2 (es) | Anticuerpos anti-glucagón | |
| EP2809261A4 (en) | DEVICE FOR THE COMPARTMENTAL EXPANSION OF BLOOD VESSELS | |
| MX2020001835A (es) | Métodos para el tratamiento de retinopatía diabética y otras enfermedades oftálmicas. | |
| DOP2017000013A (es) | Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
| LT2916860T (lt) | Diabeto gydymui skirta kompozicija, apimanti oksintomodulino analogą | |
| EP2793932A4 (en) | CTP BASED INSULIN ANALOGUES FOR THE TREATMENT OF DIABETES | |
| CR20150358A (es) | Derivados de exendina-4 fucionalizada | |
| CO6761400A2 (es) | Combinación de análogos de glucagón acilados con análogos de insulina | |
| CO7240369A2 (es) | Ácido 5-aminotetrahidroquinolin-2-carboxílicos novedosos y su uso | |
| CR20110509A (es) | Composicion farmaceutica | |
| NZ707139A (en) | Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level | |
| MX2014013858A (es) | Metodo para tratar un cancer positivo de gd2. | |
| GT201400162A (es) | Composición y método para el diagnóstico y el tratamiento de las enfermedades asociadas a la degeneración de las neuritas | |
| MX2015012444A (es) | Metodos de diagnostico, seleccion y tratamiento de enfermedades y afecciones provocadas por o asociadas con metanogenos. | |
| BR112014011223A8 (pt) | Método de tratar uma doença proliferativa | |
| UY35439A (es) | Formas salinas del (2-(2-(4-fluorofenil)tiazol-4-il)propan-2-il)carbamato de (S)-quinuclidin-3-ilo. | |
| CR20160290A (es) | Inhibidores tetracíclicos de autotaxina | |
| EA201201296A1 (ru) | Способы лечения диабетических язв стопы | |
| MX2015007719A (es) | Terapia dirigida del receptor del factor de crecimiento epidermico (egfr) de trastornos neurologicos y dolor. |